Dashboard

MRK

Merck & Co., Inc.

NYSE · USD · Stock

$149.52

+0.24 (+0.16%)

past month

Closed
Market cap
$368.89B
P/E
151.03
Yield
2.27%
Volume
12.3M
52 weeks
$82.01 – $157

About

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands.

Merck & Co., Inc. (MRK) is a healthcare company listed on NYSE, traded in USD. Over the past year it moved between $82.01 and $156.92, and it pays a dividend every quarter.

  • Healthcare
  • Drug Manufacturers - General
  • Rahway, United States
  • 73K employees
  • Led by Robert M. Davis J.D.

Financials

Revenue, last 12 months

$67.38B+4.70%

2022202320242025

Earnings

Beat the estimate

4 of 4 quarters

  • Q4 2025

    +1.47%

  • Q1 2026

    +13.15%

  • Q2 2026

    +49.43%

  • Q3 2026

    +19.30%

Earnings per share, last 12 months $0.9900

Analysts

26 analysts say

Buy

12-month target$159.83+6.90%

Dividends

Yield · per share, yearly

2.27%$3.40

Split 1,048-for-1,000 on Jun 3, 2021

Ownership

Institutions
82.88%
Insiders
0.06%

Latest insider trade Aug 13, 2026, GUINDO CHIRFI

Prices from Yahoo Finance, may be delayed